These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17593372)

  • 21. Neuroimaging of pediatric craniopharyngiomas: a pictorial essay.
    Rossi A; Cama A; Consales A; Gandolfo C; Garrè ML; Milanaccio C; Pavanello M; Piatelli G; Ravegnani M; Tortori-Donati P
    J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():299-319. PubMed ID: 16700305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression.
    Kaser A; Nagata S; Tilg H
    Cytokine; 1999 Oct; 11(10):736-43. PubMed ID: 10525311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Craniopharyngiomas of childhood: the CHLA experience.
    Sosa IJ; Krieger MD; McComb JG
    Childs Nerv Syst; 2005 Aug; 21(8-9):785-9. PubMed ID: 15965667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent craniopharyngiomas: therapeutic alternatives.
    Sweet WH
    Clin Neurosurg; 1980; 27():206-29. PubMed ID: 7273555
    [No Abstract]   [Full Text] [Related]  

  • 25. Interferon or late effect of radiotherapy?
    Sandvik U; Grillner P; Holm S; Gustavsson B
    Childs Nerv Syst; 2016 Feb; 32(2):229-30. PubMed ID: 26759021
    [No Abstract]   [Full Text] [Related]  

  • 26. Radiological findings following postsurgical intratumoral bleomycin injection for cystic craniopharyngioma.
    Kim SD; Park JY; Park J; Lee JB; Kim SH; Lim DJ
    Clin Neurol Neurosurg; 2007 Apr; 109(3):236-41. PubMed ID: 17046151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracystic treatments for craniopharyngioma.
    Steinbok P; Hukin J
    Neurosurg Focus; 2010 Apr; 28(4):E13. PubMed ID: 20367357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance cystography with gadopenetate dimeglumine of a cystic craniopharyngioma in a child - a technical note.
    Greenberg SB; Magram G
    Pediatr Radiol; 2000 Feb; 30(2):85-6. PubMed ID: 10663517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Craniopharyngiomas in children: Turkey experience.
    Erşahin Y; Yurtseven T; Ozgiray E; Mutluer S
    Childs Nerv Syst; 2005 Aug; 21(8-9):766-72. PubMed ID: 16001286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of bleomycin in intratumoral chemotherapy for cystic craniopharyngioma. Case report.
    Cavalheiro S; Sparapani FV; Franco JO; da Silva MC; Braga FM
    J Neurosurg; 1996 Jan; 84(1):124-6. PubMed ID: 8613819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric craniopharyngioma--rationale for multimodal management: the Egyptian experience.
    Hafez MA; ElMekkawy S; AbdelBadie H; Mohy M; Omar M
    J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():371-80. PubMed ID: 16700313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radical resection of craniopharyngioma.
    Zuccaro G
    Childs Nerv Syst; 2005 Aug; 21(8-9):679-90. PubMed ID: 16133275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Craniopharyngiomas: our experience in Lyon.
    Mottolese C; Szathmari A; Berlier P; Hermier M
    Childs Nerv Syst; 2005 Aug; 21(8-9):790-8. PubMed ID: 15971075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracystic chemotherapy with bleomycin in the treatment of craniopharyngiomas.
    Mottolese C; Stan H; Hermier M; Berlier P; Convert J; Frappaz D; Lapras C
    Childs Nerv Syst; 2001 Dec; 17(12):724-30. PubMed ID: 11862438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathological changes and protection of hypothalamus in pediatric craniopharyngioma].
    Zhang Y; Wang Z; Ma Z
    Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):280-2. PubMed ID: 11798773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TNF-α confers resistance to Fas-mediated apoptosis in rheumatoid arthritis through the induction of soluble Fas.
    Hong S; Kim EJ; Lee EJ; San Koo B; Min Ahn S; Bae SH; Lim DH; Kim YG; Yoo B; Lee CK
    Life Sci; 2015 Feb; 122():37-41. PubMed ID: 25529148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
    Toomey NL; Deyev VV; Wood C; Boise LH; Scott D; Liu LH; Cabral L; Podack ER; Barber GN; Harrington WJ
    Oncogene; 2001 Oct; 20(48):7029-40. PubMed ID: 11704827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term neurological, visual, and endocrine outcomes following transnasal resection of craniopharyngioma.
    Chakrabarti I; Amar AP; Couldwell W; Weiss MH
    J Neurosurg; 2005 Apr; 102(4):650-7. PubMed ID: 15871507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Craniopharyngiomas.
    Karavitaki N; Wass JA
    Endocrinol Metab Clin North Am; 2008 Mar; 37(1):173-93, ix-x. PubMed ID: 18226736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation.
    Nomura S; Ishii K; Inami N; Uoshima N; Ishida H; Yoshihara T; Kitayama H; Hayashi K
    Transpl Immunol; 2007 Nov; 18(2):115-21. PubMed ID: 18005854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.